Last edition
News about
BELLUS Health Convenes Virtual KOL Meeting to Discuss the State of Chronic Cough Treatment
Bellus a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that it will convene a virtual Key Opinion Leader (KOL) meeting to discuss the chronic cough landscape on Wednesday, May 27, 2020 at 9:00 a.m. EDT
Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements
Lupin Extends Jan Kovid Helpline for Bhopal and Indore Citizens
Pharma major Lupin Limited (Lupin) today announced the extension of the Jan Kovid Helpline (1800-572-6130) for the residents of Bhopal and Indore
Regeneron PharmaceuticalsInc and the Colorado Center for Personalized Medicine (CCPM) at the University of ColoradoAnschutz Medical Campus, announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine
Cipla Limited has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine remdesivir, which has been issued an Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) to treat COVID-19 patients
FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
Today, the U.S. Food and Drug Administration took important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area
Merck's foundational CRISPR-Cas9 technology receives US patnet
Merck, a leading science and technology company, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States
Bayer to Present Data from Growing Oncology Portfolio at the ASCO20 Virtual Scientific Program
Data from Bayer's growing oncology portfolio will be presented at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, taking place from May 29-31, 2020
FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens
Today, the U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing
Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers in patients whose tumors have an alteration (mutation or fusion) in a specific gene
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy